Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to $223.0.

  • Cannabis Bioscience International Holdings' Cash & Equivalents fell 7698.66% to $223.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $223.0, marking a year-over-year decrease of 7698.66%. This contributed to the annual value of $12952.0 for FY2025, which is 161549.67% up from last year.
  • According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' Cash & Equivalents is $223.0, which was down 7698.66% from $12952.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year Cash & Equivalents high stood at $25655.0 for Q1 2023, and its period low was $223.0 during Q3 2025.
  • Its 4-year average for Cash & Equivalents is $7421.8, with a median of $2857.5 in 2023.
  • In the last 5 years, Cannabis Bioscience International Holdings' Cash & Equivalents plummeted by 9860.1% in 2023 and then skyrocketed by 161549.67% in 2025.
  • Cannabis Bioscience International Holdings' Cash & Equivalents (Quarter) stood at $24089.0 in 2022, then crashed by 98.6% to $337.0 in 2023, then skyrocketed by 124.04% to $755.0 in 2024, then crashed by 70.46% to $223.0 in 2025.
  • Its Cash & Equivalents was $223.0 in Q3 2025, compared to $12952.0 in Q2 2025 and $755.0 in Q1 2025.